Matthew Barker

Matthew Barker currently serves as the Vice President of Transformation & Strategy at CNX Therapeutics, a position held since January 2024. Prior to this role, Matthew was the Vice Chair of the Board of Trustees at Crossroads Braintree & Chelmsford Ltd from February 2021 to October 2024 and worked at McKinsey & Company from July 2022 to January 2024 in the Healthcare & Life Sciences sector. Matthew also held the position of Director of Corporate Strategy at Vectura Group plc. from February 2020 to July 2022 and served as a Healthcare Analyst at Redburn from November 2016 to February 2020. Earlier in the career, Matthew was a Senior Consultant at Deloitte UK from September 2013 to November 2016 and an Investment Banking Summer Analyst at RBS Markets & International Banking in July and September 2012. Matthew Barker graduated with a degree in Chemistry from Durham University and attended Stockport Grammar School.